Production, export of pain relief drugs halted over reports of opioid crisis in West Africa – The Hindu

February 24, 2025e-Paper
The Hindu On Books Books of the week, reviews, excerpts, new titles and features.
Data Point Decoding the headlines with facts, figures, and numbers
First Day First Show News and reviews from the world of cinema and streaming.
Health Matters Ramya Kannan writes to you on getting to good health, and staying there
The View From India Looking at World Affairs from the Indian perspective.
Science For All The weekly newsletter from science writers takes the jargon out of science and puts the fun in!
Karnataka Today Your daily dose of news highlights from Karnataka
Today's Cache Your download of the top 5 technology stories of the day.
February 24, 2025e-Paper
Updated – February 24, 2025 11:22 am IST – New Delhi
While Tapentadol is an opioid medication that is used to treat moderate to severe pain, Carisoprodol is a muscle relaxant which works on the centres in the brain and spinal cord to relieve pain. Representational image. | Photo Credit: REUTERS
The apex drug regulatory authority has prohibited the production and export of all combinations of pain relief medicines tapentadol and carisoprodol, over news reports that unapproved combinations of the drugs exported to West African countries are driving an opioid crisis there.
In a communication, the Drugs Controller General of India (DCGI) has asked the drug control authorities of States and Union Territories to withdraw all export NOCs and permission to manufacture all combinations of the two drugs.
Tapentadol is an opioid medication that is used to treat moderate to severe pain. Carisoprodol is a muscle relaxant which works on the centres in the brain and spinal cord to relieve pain.
Both Tapentadol and Carisoprodol are approved individually by Central Drugs Standard Control Organisation (CDSCO) but not approved as a combination in the country. Also, they are not part of the NDPS drugs list in India.
"This is in connection with a recent article from BBC whereby, it has been written that the combination drug Tapentadol and Carisoprodol has significant abuse potential and this combination is being exported to West African countries from India," the communication sent by the DCGI on Friday said.
Looking into the potential to have a harmful impact on people, the DCGI requested an immediate withdrawal of all export NOCs and permission to manufacture, issued for all combinations of tapentadol and carisoprodol.
Published – February 24, 2025 11:20 am IST
generic drugs / exports
Copyright© 2025, THG PUBLISHING PVT LTD. or its affiliated companies. All rights reserved.
BACK TO TOP
Terms & conditions  |  Institutional Subscriber
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.

source

About The Author

admin

See author's posts